Kowalczyk P - Search Results

1

Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.

Kowalczyk P, Sałat K, Höfner GC, Mucha M, Rapacz A, Podkowa A, Filipek B, Wanner KT, Kulig K. Kowalczyk P, et al. Eur J Med Chem. 2014 Aug 18;83:256-73. doi: 10.1016/j.ejmech.2014.06.024. Epub 2014 Jun 12. Eur J Med Chem. 2014. PMID: 24973660

2

GABA system as a target for new drugs.

Kowalczyk P, Kulig K. Kowalczyk P, et al. Curr Med Chem. 2014;21(28):3294-309. doi: 10.2174/0929867321666140601202158. Curr Med Chem. 2014. PMID: 24934345 Review.

3

Synthesis and pharmacological evaluation of new 4,4-diphenylbut-3-enyl derivatives of 4-hydroxybutanamides as GABA uptake inhibitors.

Kowalczyk P, Höfner G, Wanner KT, Kulig K. Kowalczyk P, et al. Acta Pol Pharm. 2012 Jan-Feb;69(1):157-60. Acta Pol Pharm. 2012. PMID: 22574521 Free article. No abstract available.

4

2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.

Kowalczyk P, Sałat K, Höfner GC, Guzior N, Filipek B, Wanner KT, Kulig K. Kowalczyk P, et al. Bioorg Med Chem. 2013 Sep 1;21(17):5154-67. doi: 10.1016/j.bmc.2013.06.038. Epub 2013 Jun 26. Bioorg Med Chem. 2013. PMID: 23859778

5

Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression.

Sałat K, Podkowa A, Kowalczyk P, Kulig K, Dziubina A, Filipek B, Librowski T. Sałat K, et al. Among authors: kowalczyk p. Pharmacol Rep. 2015 Jun;67(3):465-72. doi: 10.1016/j.pharep.2014.11.003. Epub 2014 Nov 21. Pharmacol Rep. 2015. PMID: 25933955

6

New investigational drugs for the treatment of neuropathic pain.

Sałat K, Kowalczyk P, Gryzło B, Jakubowska A, Kulig K. Sałat K, et al. Among authors: kowalczyk p. Expert Opin Investig Drugs. 2014 Aug;23(8):1093-104. doi: 10.1517/13543784.2014.916688. Epub 2014 Jun 4. Expert Opin Investig Drugs. 2014. PMID: 24896842 Review.

7

Epicutaneous (EC) immunization with type II collagen (COLL II) induces CD4(+) CD8(+) T suppressor cells that protect from collagen-induced arthritis (CIA).

Marcińska K, Majewska-Szczepanik M, Lazar A, Kowalczyk P, Biała D, Woźniak D, Szczepanik M. Marcińska K, et al. Among authors: kowalczyk p. Pharmacol Rep. 2016 Apr;68(2):483-9. doi: 10.1016/j.pharep.2015.11.004. Epub 2015 Nov 25. Pharmacol Rep. 2016. PMID: 26922557

8

Corrigendum to "Oral treatment with enrofloxacin early in life promotes Th2-mediated immune response in mice" [Pharmacol. Rep. 68 (2016) 44-50].

Strzępa A, Majewska-Szczepanik M, Kowalczyk P, Woźniak D, Motyl S, Szczepanik M. Strzępa A, et al. Among authors: kowalczyk p. Pharmacol Rep. 2017 Jun;69(3):588. doi: 10.1016/j.pharep.2017.01.018. Epub 2017 Mar 29. Pharmacol Rep. 2017. PMID: 28365255 No abstract available.

9

Cyclophosphamide-modified murine peritoneal macrophages induce CD4⁺ T contrasuppressor cells that protect contact sensitivity T effector cells from suppression.

Majewska-Szczepanik M, Kowalczyk P, Biała D, Marcińska K, Strzępa A, Woźniak D, Sura P, Pearson J, Wen L, Szczepanik M. Majewska-Szczepanik M, et al. Among authors: kowalczyk p. Pharmacol Rep. 2018 Aug;70(4):796-803. doi: 10.1016/j.pharep.2018.02.015. Epub 2018 Feb 23. Pharmacol Rep. 2018. PMID: 29957340

10

[No title available]

[No authors listed] [No authors listed] PMID: 31994079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page